ORPEA chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 69.90
Dividend & YieldN/A€ (N/A)
Beta 1.02
Market capitalization 159.93M
Operating cash flow 711.24M
ESG Scores 30.8

Company description

ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. The company's post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state. Its psychiatric hospitals provide services for the patients with mood disorders, anxiety disorders, obsessive-compulsive disorders, addictions, eating disorders, sleep disorders, personality disorders, ageing-related psychiatric disorders, psychosis, over exhaustion or burn-out, chronic fatigue syndrome, fibromyalgia, psychosomatic conditions, and post-traumatic stress disorder conditions, as well as geriatric, child, young adult, parent-child, and public/private patients psychiatry services. In addition, the company offers home care services, including housekeeping services, such as cleaning, meals, ironing, gardening, and household errands; daily life assistance services comprising day or night supervision, assistance with hygiene tasks, and meal-time assistance; and movement assistance services. The company operates in France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China. ORPEA SA was founded in 1989 and is headquartered in Puteaux, France.

Sector: Healthcare - Industry: Medical Care Facilities

Financial Ratios
Quick Ratio0.91
Working Capital-0.72
Return On Equity0.05
Debt To Equity1.86
Fixed Asset Ratio0.2
Fixed Interest Cover2.17

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 34.16M -8.7M 57.13M 25.38M
Total Cashflows From Investing Activities -959.7M -978.25M -1.01B -1.41B
Net Borrowings 905.89M 535.03M 500.46M 1.03B
Total Cash From Financing Activities 698.67M 242.54M 285.8M 718.3M
Change To Operating Activities -80.36M -22.93M -129.52M -23.81M
Issuance Of Stock
Net Income 220.39M 233.99M 160.05M 65.19M
Change In Cash 154.09M 70.75M 50.09M 63.53M
Effect Of Exchange Rate
Total Cash From Operating Activities 415.11M 806.46M 777.73M 753.75M
Depreciation 182.1M 206.69M 214.74M 572.05M
Change To Account Receivables -23.82M -32.59M 30.26M -198.41M
Other Cashflows From Financing Activities -136.17M -214.95M -214.66M -248.9M
Change To Netincome 52.59M 432.79M 405.85M 257.88M
Capital Expenditures -264.27M -276.15M -494.44M -421.91M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development
Income Before Tax 316.38M 331.38M 211.88M 104.4M
Net Income 220.39M 233.99M 160.05M 65.19M
Selling General Administrative 354M 354M 354M
Gross Profit 701.86M 1.04B 963.25M 1.02B
Ebit 427.69M 503.78M 422.9M 391.73M
Operating Income 427.69M 503.78M 422.9M 391.73M
Interest Expense -100.98M -120.12M -155.61M -130.29M
Income Tax Expense 95.31M 98.61M 52.58M 37.54M
Total Revenue 3.42B 3.74B 3.92B 4.3B
Cost Of Revenue 2.72B 2.7B 2.96B 3.27B
Total Other Income ExpenseNet -111.31M -172.4M -211.02M -287.33M
Net Income From Continuing Ops 221.07M 232.77M 159.3M 66.86M
Net Income Applicable To Common Shares 220.39M 233.99M 160.05M 65.19M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 8.17B 11.53B 13.48B 15.17B
Total Stockholder Equity 2.97B 3.01B 3.5B 3.8B
Other Current Liabilities 537.5M 365.94M 649.02M 687.29M
Total Assets 11.14B 14.54B 16.97B 18.98B
Common Stock 80.73M 80.77M 80.79M 80.8M
Other Current Assets 210.01M 403.06M 554.9M 391.39M
Retained Earnings 220.39M 233.99M 160.05M 65.19M
Treasury Stock 2.67B 2.7B 3.25B 3.65B
Cash 767.99M 838.74M 888.84M 952.37M
Total Current Liabilities 1.94B 2.18B 2.63B 3.54B
Other Stockholder Equity 2.67B 2.7B 3.25B 3.65B
Property, Plant, and Equipment 5.71B 8.35B 9.79B 11.14B
Total Current Assets 1.84B 2.1B 2.41B 2.8B
Net Tangible Assets -424.55M -754.01M -880.56M -939.82M
Net Receivables 806.55M 806.15M 899.65M 1.4B
Accounts Payable 268.46M 253.78M 310.42M 334.8M


Insider Transactions

Here are the insider transactions of stock shares related to ORPEA:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NO DATA

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to ORPEA. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on ORPEA

Here is the result of two systematic investment strategies applied to ORPEA. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on ORPEA

The following chart shows the equity curve of the two systematic investment strategies applied to ORPEA:

ORPEA automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -11.56% on the backtest period.

Performance at glance

Performance

-11.56 %

Latent gain

-190.06 €

Invested capital

1643.5 €

Annualized return

-2.82 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on ORPEA

This is the result of two momentum investment strategies applied to ORPEA. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on ORPEA

The following chart shows all the entries opened by the momentum investment system on ORPEA:

ORPEA momentum entries
  • The first momentum investment strategy would give -10.26% of return on ORPEA. That represents -508.9€ of latent gain with 4960.06€ of employed capital.
  • The second momentum investment strategy would give -12.31% of return on ORPEA. That represents -395.26€ of latent gain with 3211.3€ of employed capital.
Performance at glance (1Q Momentum)

Performance

-10.26 %

Latent gain

-508.9 €

Invested capital

4960.06 €

Annualized return

0.0 %
Performance at glance (2Q Momentum)

Performance

-12.31 %

Latent gain

-395.26 €

Invested capital

3211.3 €

Annualized return

-3.4 %

Momentum equity curve on ORPEA

The following chart shows the equity curve of the two momentum strategies applied to ORPEA:

ORPEA momentum equity

Note: the dividends potentially given by ORPEA are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on ORPEA

The following chart shows the employed capital evolution of the two momentum strategies on ORPEA since the beginning:

ORPEA

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250€, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000€.


Buy the dip strategy result on ORPEA

Buy the dip entry openings on ORPEA

ORPEA

The performance achieved by the robo-advisor on ORPEA is 0%. That represents 0.0$ of latent gain with 0.0€ of employed capital. The following chart shows ORPEA stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of ORPEA, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 €

Invested capital

0.0 €

Annualized return

0.0 %

Equity curve of the strategy applied to ORPEA

The following chart shows the result of the investment strategy applied to ORPEA:

ORPEA

Note: the dividends potentially given by ORPEA are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on ORPEA

The following chart shows the employed capital evolution since the beginning of the investment strategy on ORPEA:

ORPEA

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on ORPEA

In this section, I will compare the three previous investment strategies applied to ORPEA.

Equity curve comparison on ORPEA

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

ORPEA investment strategy comparison

Employed capital comparison on ORPEA

ORPEA investment comparison

Performance comparison on ORPEA

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -11.56% -190.06€ 1643.5€ -2.82%
Momentum 1 quarter -10.26% -508.9€ 4960.06€ -2.66%
Momentum 2 quarters -12.31% -395.26€ 3211.3€ -3.4%
Non-directional 0% 0.0€ 0.0€ 0.0%
Annualized return comparison

Automatic investment

-2.82 %

Momentum 1Q

-3.4 %

Momentum 2Q

-3.4 %

Non-directional

0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with ORPEA:

Positive correlations

Most correlated stocks this year

  • ORPEA

  • Most correlated stocks last 3 months

  • ORPEA

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months


    Note: The algorithm computes the probability of correlation between ORPEA and the other stocks. There may be false positives or some missing correlated stocks. If the price of ORPEA does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name ORPEA
    Country France
    City Puteaux
    Address 12, rue Jean-JaurEs
    Phone 33 1 47 75 78 07
    Website www.orpea-corp.com
    FullTime employees 71000
    Industry Medical Care Facilities
    Sector Healthcare
    Exchange XPAR
    Ticker ORP.XPAR
    Market www.euronext.com

    ORPEA ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 3.2
    Peer Environment Performance 2.6416666666667
    Environment Percentile unknown
    Palm Oil no
    Nuclear no
    Fur Leather no
    GMO no
    Coal no
    Pesticides no
    Animal Testing no

    Social scores

    Social ESG Factors Scores
    Social Score 20.0
    Peer Social Performance 12.131111111111
    Social Percentile unknown
    Highest Controversy 4
    Peer Highest Controversy Performance 1.6486486486486
    Adult no
    Gambling no
    Alcoholic no
    Tobacco no
    Catholic no
    Controversial Weapons no
    Small Arms no
    Military Contract no
    Peer Count yes

    Related Controversy: Customer Incidents


    Governance scores

    Governance ESG Factors Scores
    Governance Score 7.6
    Peer Governance Performance 7.7769444444444
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: 30.8
    Environment Score: 3.2
    Social Score: 20.0
    Governance Score: 7.6

    ESG Performance: OUT_PERF

    Peer Group: Healthcare

    Peer Esg Score Performance: 22.573513513514

    Rating Year: 2023

    Rating Month: 1

    Max Age: 86400

    Percentile: 68